Tag: Samsung Biologics
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Samsung Biologics to manufacture Moderna’s COVID-19 vaccine in South Korea
Global biotechnology company Moderna has inked a manufacturing services and supply agreement with Samsung Biologics under which the South Korea-based contract development and manufacturing...
Featured Article
Sydney to spotlight the latest in manufacturing at AMW 2024
With the Australian Manufacturing Week (AMW) 2024 fast approaching, Sydney is set to become the epicentre of groundbreaking innovations in the advanced manufacturing sector.Â
